LSE:SPI

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Spire Healthcare Group

Market Cap

UK£1.0b

Last Updated

2021/06/19 11:14 UTC

Data Sources

Company Financials +

Executive Summary

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. More Details


Snowflake Analysis

Moderate growth potential and slightly overvalued.


Similar Companies

Share Price & News

How has Spire Healthcare Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SPI is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: SPI's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.


Market Performance


7 Day Return

1.4%

SPI

0.02%

GB Healthcare

0.1%

GB Market


1 Year Return

181.5%

SPI

56.6%

GB Healthcare

18.7%

GB Market

Return vs Industry: SPI exceeded the UK Healthcare industry which returned 56.6% over the past year.

Return vs Market: SPI exceeded the UK Market which returned 18.7% over the past year.


Shareholder returns

SPIIndustryMarket
7 Day1.4%0.02%0.1%
30 Day32.5%7.9%1.4%
90 Day53.0%22.6%7.2%
1 Year181.5%181.5%58.8%56.6%24.6%18.7%
3 Year3.9%-0.4%6.2%1.5%14.5%1.3%
5 Year-19.2%-24.5%-13.4%-19.1%47.6%19.9%

Long-Term Price Volatility Vs. Market

How volatile is Spire Healthcare Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Spire Healthcare Group undervalued compared to its fair value and its price relative to the market?

13.2%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: SPI (£2.52) is trading below our estimate of fair value (£2.9)

Significantly Below Fair Value: SPI is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: SPI is unprofitable, so we can't compare its PE Ratio to the UK Healthcare industry average.

PE vs Market: SPI is unprofitable, so we can't compare its PE Ratio to the UK market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SPI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SPI is good value based on its PB Ratio (1.4x) compared to the GB Healthcare industry average (2.6x).


Future Growth

How is Spire Healthcare Group forecast to perform in the next 1 to 3 years based on estimates from 7 analysts?

37.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SPI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.9%).

Earnings vs Market: SPI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: SPI's is expected to become profitable in the next 3 years.

Revenue vs Market: SPI's revenue (5.1% per year) is forecast to grow slower than the UK market (5.3% per year).

High Growth Revenue: SPI's revenue (5.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SPI's Return on Equity is forecast to be low in 3 years time (3.2%).


Past Performance

How has Spire Healthcare Group performed over the past 5 years?

-84.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SPI is currently unprofitable.

Growing Profit Margin: SPI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: SPI is unprofitable, and losses have increased over the past 5 years at a rate of 84.5% per year.

Accelerating Growth: Unable to compare SPI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SPI is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (13.3%).


Return on Equity

High ROE: SPI has a negative Return on Equity (-33.1%), as it is currently unprofitable.


Financial Health

How is Spire Healthcare Group's financial position?


Financial Position Analysis

Short Term Liabilities: SPI's short term assets (£250.1M) do not cover its short term liabilities (£253.9M).

Long Term Liabilities: SPI's short term assets (£250.1M) do not cover its long term liabilities (£1.1B).


Debt to Equity History and Analysis

Debt Level: SPI's debt to equity ratio (60.1%) is considered high.

Reducing Debt: SPI's debt to equity ratio has increased from 42.4% to 60.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable SPI has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: SPI is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 28.4% per year.


Dividend

What is Spire Healthcare Group current dividend yield, its reliability and sustainability?

0.96%

Forecast Dividend Yield


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SPI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SPI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SPI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SPI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: SPI is not paying a notable dividend for the UK market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SPI's dividend in 3 years as they are not forecast to pay a notable one for the UK market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.7yrs

Average management tenure


CEO

Justin Ash

3.67yrs

Tenure

UK£1,177,200

Compensation

Mr. Justin J. Ash, BA (Hons), has been the Chief Executive Officer and Executive Director of Spire Healthcare Group Plc since October 30, 2017. Mr. Ash served as the Chief Executive Officer at Oasis Health...


CEO Compensation Analysis

Compensation vs Market: Justin's total compensation ($USD1.64M) is about average for companies of similar size in the UK market ($USD1.37M).

Compensation vs Earnings: Justin's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: SPI's management team is considered experienced (2.7 years average tenure).


Board Members

Experienced Board: SPI's board of directors are considered experienced (3.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Spire Healthcare Group plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Spire Healthcare Group plc
  • Ticker: SPI
  • Exchange: LSE
  • Founded: 2007
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: UK£1.012b
  • Shares outstanding: 400.84m
  • Website: https://www.spirehealthcare.com

Number of Employees


Location

  • Spire Healthcare Group plc
  • 3 Dorset Rise
  • London
  • Greater London
  • EC4Y 8EN
  • United Kingdom

Listings


Biography

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It offers various treatments in the areas of allergy and infectious diseas...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/19 11:14
End of Day Share Price2021/06/18 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.